KCR

KCR is an international full-service contract research organization providing clinical development solutions for the biotechnology and pharmaceutical industries. It offers comprehensive support throughout the entire clinical trial life cycle and operates globally with major hubs in Boston (US), Berlin (Germany), Warsaw (Poland), Kyiv (Ukraine), and Sydney (Australia). In August 2024, it was acquired by ICON plc but continues to operate as part of ICON’s global network. The company specializes in trial execution, consulting, and placement/recruitment services for pharma/biotech clients. Therapeutic expertise includes oncology, immunology, central nervous system disorders (CNS), and vaccines. Employs over 700 staff worldwide as of recent reports. Known for innovative approaches to functional service provision and digital/decentralized trial solutions. No proprietary pipeline or drugs under development—focuses on supporting client-sponsored programs through all phases of clinical research.